Lead sponsor
National Neuroscience Institute
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
100
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVDAlzheimer's diseasePh 4Completed100